Literature DB >> 2176152

Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an AP1 binding site.

R C Nicholson1, S Mader, S Nagpal, M Leid, C Rochette-Egly, P Chambon.   

Abstract

Stromelysin is a member of the metalloproteinase family which plays an important role in extracellular matrix remodelling during many normal and disease processes. We show here that in polyomavirus-transformed rat embryo fibroblast cells (PyT21), the transcription from the stromelysin gene is repressed by the vitamin A derivative retinoic acid (RA). Furthermore, expression vectors encoding the human RA receptors hRAR-alpha, hRAR-beta and hRAR-gamma repress chloramphenicol acetyltransferase (CAT) expression from stromelysin promoter-CAT gene expression vectors in RA-treated PyT21 and human HeLa cells, as determined by transient transfection assays. Through mutation and deletion analysis, we show that the RA dependent repression is mediated by a 25 bp region from nucleotide positions -72 to -48 of the rat stromelysin 5'-flanking DNA sequence. Further mutation analysis of this region indicates that the DNA sequence required for RA dependent repression colocalizes with an AP1 binding site which is essential for promoter activity. We show also that RA represses the transcriptional activity of a reporter gene containing a TPA responding AP1 binding site driving the HSV tk promoter. Thus the RAR-RA complex appears to repress transcription of the stromelysin gene by blocking activation by positive regulatory factors. However, we found no evidence supporting the possibility that the RA dependent repression could be due to RAR binding to the AP1 binding site or to the AP1 components c-fos and c-jun.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2176152      PMCID: PMC552237          DOI: 10.1002/j.1460-2075.1990.tb07895.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  87 in total

1.  A novel steroid thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma.

Authors:  H de Thé; A Marchio; P Tiollais; A Dejean
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

2.  The complete primary structure of human matrix metalloproteinase-3. Identity with stromelysin.

Authors:  J Saus; S Quinones; Y Otani; H Nagase; E D Harris; M Kurkinen
Journal:  J Biol Chem       Date:  1988-05-15       Impact factor: 5.157

3.  Neutral metallo-proteinases of rabbit bone. Separation in latent forms of distinct enzymes that when activated degrade collagen, gelatin and proteoglycans.

Authors:  A Sellers; J J Reynolds; M C Meikle
Journal:  Biochem J       Date:  1978-05-01       Impact factor: 3.857

4.  A versatile in vivo and in vitro eukaryotic expression vector for protein engineering.

Authors:  S Green; I Issemann; E Sheer
Journal:  Nucleic Acids Res       Date:  1988-01-11       Impact factor: 16.971

5.  Identification of a receptor for the morphogen retinoic acid.

Authors:  V Giguere; E S Ong; P Segui; R M Evans
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

6.  A 13 bp palindrome is a functional estrogen responsive element and interacts specifically with estrogen receptor.

Authors:  L Klein-Hitpass; G U Ryffel; E Heitlinger; A C Cato
Journal:  Nucleic Acids Res       Date:  1988-01-25       Impact factor: 16.971

7.  An early effect of retinoic acid: cloning of an mRNA (Era-1) exhibiting rapid and protein synthesis-independent induction during teratocarcinoma stem cell differentiation.

Authors:  G J LaRosa; L J Gudas
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

8.  Negative regulation by glucocorticoids through interference with a cAMP responsive enhancer.

Authors:  I E Akerblom; E P Slater; M Beato; J D Baxter; P L Mellon
Journal:  Science       Date:  1988-07-15       Impact factor: 47.728

9.  Identification of a second human retinoic acid receptor.

Authors:  N Brand; M Petkovich; A Krust; P Chambon; H de Thé; A Marchio; P Tiollais; A Dejean
Journal:  Nature       Date:  1988-04-28       Impact factor: 49.962

Review 10.  The steroid and thyroid hormone receptor superfamily.

Authors:  R M Evans
Journal:  Science       Date:  1988-05-13       Impact factor: 47.728

View more
  74 in total

1.  Modulation of CRX transactivation activity by phosducin isoforms.

Authors:  X Zhu; C M Craft
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

2.  Nonsurgical innovations in the treatment of nonmelanoma skin cancer.

Authors:  Sadegh Amini; Martha H Viera; Whitney Valins; Brian Berman
Journal:  J Clin Aesthet Dermatol       Date:  2010-06

3.  Retinoic acid is a negative regulator of AP-1-responsive genes.

Authors:  R Schüle; P Rangarajan; N Yang; S Kliewer; L J Ransone; J Bolado; I M Verma; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

4.  Inhibition of gelatinase activity in human airway epithelial cells and fibroblasts by dexamethasone and beclomethasone.

Authors:  J E Carver; W A Galloway; C Robinson
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

5.  Retinoic acid repression of bone morphogenetic protein 4 in inner ear development.

Authors:  Deborah L Thompson; Lisa M Gerlach-Bank; Kate F Barald; Ronald J Koenig
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

6.  Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells.

Authors:  Z Dong; M J Birrer; R G Watts; L M Matrisian; N H Colburn
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

7.  Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro.

Authors:  T K Kerppola; D Luk; T Curran
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

8.  Stromelysin 3 is overexpressed in human pancreatic carcinoma and regulated by retinoic acid in pancreatic carcinoma cell lines.

Authors:  Z von Marschall; E O Riecken; S Rosewicz
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

9.  Retinoic acid modulates retinaldehyde dehydrogenase 1 gene expression through the induction of GADD153-C/EBPbeta interaction.

Authors:  Guillermo Elizondo; Irma M Medina-Díaz; Raymundo Cruz; Frank J Gonzalez; Libia Vega
Journal:  Biochem Pharmacol       Date:  2008-10-17       Impact factor: 5.858

10.  Loss of retinoic acid receptor gamma function in F9 cells by gene disruption results in aberrant Hoxa-1 expression and differentiation upon retinoic acid treatment.

Authors:  J F Boylan; D Lohnes; R Taneja; P Chambon; L J Gudas
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.